Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound could help heart failure patients go home sooner

NCT ID NCT06965712

Symptom relief Sponsor: Florida International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests whether using a bedside ultrasound (POCUS) to check fluid levels can help doctors treat heart failure patients more effectively. 66 adults hospitalized with decompensated heart failure will be randomly assigned to get either standard care or ultrasound-guided care. The goal is to see if ultrasound guidance can shorten hospital stays and reduce the chance of being readmitted within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Point-of-Care Ultrasound (POCUS) device
What this could lead to
If it works, this could mean shorter hospital stays and fewer readmissions for heart failure patients by using a simple bedside ultrasound to guide treatment.
What could go wrong
This is a small, early-stage study with only 66 participants, so results may not apply to all patients. The ultrasound is just a guide—it may not actually change outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Nov 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults aged 18 years and older. Hospitalized with a primary diagnosis of decompensated heart failure (left, right, or biventricular). Evidence of volume overload or congestion based on Framingham criteria, clinical examination, elevated proBNP (\>1000 pg/mL), or chest X-ray showing pulmonary edema. Ability to undergo bedside ultrasound evaluation (POCUS) as clinically feasible. Able to provide informed consent. Exclusion Criteria: Age under 18 years. Pregnant or breastfeeding women. Terminal illness with life expectancy \< 30 days. Inability to obtain ultrasound images due to body habitus or other technical reasons. Enrollment in another interventional clinical trial that could interfere with the outcomes of this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Decompensated heart failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Decompensated heart failure Heart failure Hospital length of stay

Contacts and locations

Locations

  • Jackson Memorial Hospital

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.